跳至主要内容
临床试验/NCT04171570
NCT04171570已完成不适用

DISCO Radial Trial: DIStal Versus COnventional RADIAL Access for Coronary Angiography and Intervention: a Randomized Multicenter Trial

Terumo Europe N.V.31 个研究点 分布在 10 个国家目标入组 1,309 人开始时间: 2019年12月10日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
1,309
试验地点
31
主要终点
Forearm radial artery occlusion (RAO) rate before discharge

研究概览

简要总结

The objective of this study is to demonstrate the superiority of Distal Radial Access (DTRA) to Conventional Transradial Access (CTRA) regarding forearm radial artery occlusion (RAO).

This trial plans to include 1300 patients in around 12 locations around the world (11 participating sites in Europe and 1 participating site in Japan).

详细描述

DISCO RADIAL is a prospective, global, open label, multi-centre randomized controlled trial with plan to include approximately 1300 patients on who transradial coronary angiography and/or intervention is performed. The patients will be randomized in 1:1 ratio to either Distal Transradial Artery Access (DTRA) or Conventional Transradial Access (CTRA) arm. In both arms 6Fr Glidesheath Slender (GSS) will be used as access sheath.

The sponsor will work in accordance with standard operating procedures (SOP) and the Monitoring Plan in order to ensure adherence to the CIP and applicable regulations at the investigational sites.

The Monitoring Plan is built according to a risk-based monitoring approach and describes the level of source data verification to be performed by the monitors.

Risk-based monitoring approach uses all available means to supervise the trial (central monitoring, remote monitoring and on-site monitoring), focusing in critical data points and issues ensuring that adequate monitoring (central, remote and on-site) at each site is completed to ensure protection of the rights and safety of the subjects and the quality and integrity of the data collected and submitted.

The sponsor shall provide training and the necessary guidelines to assist each investigational site on the data collection in the eCRF. Each site is responsible to report the available data requested by the CIP. In order to ensure data quality and avoid missing information in the eCRF, edit checks are designed during database development. In addition, Sponsor's CRA and Data Management team will be responsible to review the data and raise queries accordingly into the eCRF. An audit trail logging all data entered and edited is available within the EDC system. All source documents are maintained in the hospital files ready for inspection by the Sponsor and regulatory authorities upon request. The Sponsor will inform the investigator of the time period for retaining these records as per applicable regulatory requirements.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient is at least 18 years of age.
  • Patient has provided written informed consent.
  • Patient is undergoing diagnostic coronary angiography and/or PCI.
  • Patient is willing to comply with all protocol-required evaluations during the hospitalization.
  • Patient is suitable for both DTRA and CTRA using 6Fr GSS.

排除标准

  • Patient has a medical condition that may cause non-compliance with the protocol and/or confound the data interpretation.
  • Patients on chronic hemodialysis.
  • Patients presenting with ST-elevated myocardial infarction (STEMI).
  • Patients have chronic total occlusion (CTO) lesions in coronary artery.

结局指标

主要结局

Forearm radial artery occlusion (RAO) rate before discharge

时间窗: up to 5 days

Forearm radial artery occlusion (RAO) rate before discharge measured with Doopler Ultrasound

次要结局

  • Sheath insertion time(up to 2 days)
  • Overall bleeding according to BARC criteria(up to 5 days)
  • Rate of successful sheath insertion(up to 2 days)
  • Total procedural time(up to 2 days)
  • Patent hemostasis was achieved or not (CTRA) by reverse barbeau test(up to 5 days)
  • Pain associated with the procedure: Visual Assessment Scale (VAS)(up to 5 days)
  • Rate of access site crossover(up to 2 days)
  • Vascular access-site complication(up to 5 days)
  • Rate of distal radial artery occlusion (dRAO)(up to 5 days)
  • Puncture site bleeding according to EASY criteria(up to 5 days)
  • Rate of radial artery spasm(up to 2 days)
  • Time required to reach hemostasis(up to 5 days)

研究者

发起方
Terumo Europe N.V.
申办方类型
Industry
责任方
Sponsor

研究点 (31)

Loading locations...

相似试验